These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22116378)

  • 1. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
    Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
    Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
    Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
    J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual reality versus computer-aided exposure treatments for fear of flying.
    Tortella-Feliu M; Botella C; Llabrés J; Bretón-López JM; del Amo AR; Baños RM; Gelabert JM
    Behav Modif; 2011 Jan; 35(1):3-30. PubMed ID: 21177516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo.
    Meyerbröker K; Morina N; Emmelkamp PMG
    J Anxiety Disord; 2018 Jun; 57():48-56. PubMed ID: 29804894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behavioral therapy for public-speaking anxiety using virtual reality for exposure.
    Anderson PL; Zimand E; Hodges LF; Rothbaum BO
    Depress Anxiety; 2005; 22(3):156-8. PubMed ID: 16231290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
    Smits JA; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG; Powers MB
    Biol Psychiatry; 2014 Jun; 75(11):840-6. PubMed ID: 24237691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
    Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
    J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is virtual reality effective to motivate and raise interest in phobic children toward therapy? A clinical trial study of in vivo with in virtuo versus in vivo only treatment exposure.
    St-Jacques J; Bouchard S; Bélanger C
    J Clin Psychiatry; 2010 Jul; 71(7):924-31. PubMed ID: 20441721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis.
    Parsons TD; Rizzo AA
    J Behav Ther Exp Psychiatry; 2008 Sep; 39(3):250-61. PubMed ID: 17720136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia.
    Soravia LM; Heinrichs M; Winzeler L; Fisler M; Schmitt W; Horn H; Dierks T; Strik W; Hofmann SG; de Quervain DJ
    Depress Anxiety; 2014 May; 31(5):429-35. PubMed ID: 24265104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
    Berry AC; Rosenfield D; Smits JA
    Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional variability and sustained arousal during exposure.
    Culver NC; Stoyanova M; Craske MG
    J Behav Ther Exp Psychiatry; 2012 Jun; 43(2):787-93. PubMed ID: 22123332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic enhancement of associative fear memory in humans.
    Soeter M; Kindt M
    Neurobiol Learn Mem; 2011 Sep; 96(2):263-71. PubMed ID: 21624479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl.
    Tuerk PW; Wangelin BC; Powers MB; Smits JAJ; Acierno R; Myers US; Orr SP; Foa EB; Hamner MB
    Cogn Behav Ther; 2018 Sep; 47(5):351-371. PubMed ID: 29448886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying.
    Rothbaum BO; Anderson P; Zimand E; Hodges L; Lang D; Wilson J
    Behav Ther; 2006 Mar; 37(1):80-90. PubMed ID: 16942963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges to the traditional exposure paradigm: variability in exposure therapy for contamination fears.
    Kircanski K; Mortazavi A; Castriotta N; Baker AS; Mystkowski JL; Yi R; Craske MG
    J Behav Ther Exp Psychiatry; 2012 Jun; 43(2):745-51. PubMed ID: 22104655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample?
    Shiban Y; Brütting J; Pauli P; Mühlberger A
    J Behav Ther Exp Psychiatry; 2015 Mar; 46():133-40. PubMed ID: 25460259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.